Leveraging IV Robotics to Optimize Sterile Compounding Practices to Improve Safety

This webinar will review the rationale for the use of IV robotics, as well as the challenges with adopting this technology, including a discussion of preparing for and implementing IV robotics, the need for obtaining 'buy-in' from leadership and pharmacy staff to purchase and implement IV robotics, and the role this technology has played in improving safety. The speaker will also discuss what processes need to change prior to implementation, lessons learned from both the implementation and use of IV robotics, as well as case examples of errors that occurred prior to IV robotics use and the safety improvement from its use. The program will end with a question-and-answer period. 

Learning Objectives

1. Describe the role of robotics in the advancement of safety during sterile compounding operations.

2. Reviewed the necessary changes in clinical workflows and processes required prior to and after the implementation of IV robotics. 

3. Describe the challenges associated with obtaining buy in from leadership and pharmacy staff for the implementation of IV robotic technologies including steps taken to address perceived barriers.  

Speaker

Arpit Mehta, PharmD, MPH, MHA, CPEL, Director of Pharmacy, AHN Allegheny General Hospital

CE Accreditation

Released: April 10, 2024
Expiration: April 10, 2026

^{In support of improving patient care, this activity has been planned and implemented by Partners for Advancing Clinical Education (PACE) and Institute for Safe Medication Practices. PACE is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.}

^{Pharmacy Continuing Education
PACE designates this continuing education activity for 1.0 contact hour(s) (0.10 CEUs) of the Accreditation Council for Pharmacy Education. 
(Universal Activity Number - JA4008073-9999-24-068-H05-P/T)
Type of Activity: Knowledge} 

This activity is supported by Omnicell.